OPIOID EFFECTS AND OPIOID WITHDRAWAL DURING A 24 H DOSING INTERVAL IN PATIENTS MAINTAINED ON BUPRENORPHINE
Furkejuvvon:
LOPATKO, O.V., ET AL., OPIOID EFFECTS AND OPIOID WITHDRAWAL DURING A 24 H DOSING INTERVAL IN PATIENTS MAINTAINED ON BUPRENORPHINE. DRUG AND ALCOHOL DEPENDENCE, Vol. 69, no. 3 (2003), p. 317-322.
Ref.
120284
Sajádat:
SIIS R.854 Archivo
Palabras clave:
Buprenorfina, Drogodependencias, Fármacos, Heroína, Investigación, Programas de mantenimiento, Síndrome de abstinencia
Buprenorfina, Drogodependencias, Fármacos, Heroína, Investigación, Programas de mantenimiento, Síndrome de abstinencia
Geahča maid: OPIOID EFFECTS AND OPIOID WITHDRAWAL DURING A 24 H DOSING INTERVAL IN PATIENTS MAINTAINED ON BUPRENORPHINE
- BUPRENORPHINE DOSING REGIME IN THE MANAGEMENT OF OUT-PATIENT HEROIN WITHDRAWAL
- PREDICTORS OF OUTCOME FOR SHORT-TERM MEDICALLY SUPERVISED OPIOID WITHDRAWAL DURING A RANDOMIZED, MULTICENTER TRIAL OF BUPRENORPHINE-NALOXONE AND CLONIDINE IN THE NIDA CLINICAL TRIALS NETWORK DRUG AND ALCOHOL DEPENDENCE
- BUPRENORPHINE DOSING REGIME FOR INPATIENT HEROIN WITHDRAWAL: A SYMPTOM-TRIGGERED DOSE TITRATION STUDY
- THE USE OF INTRAVENOUS BUPRENORPHINE FOR THE TREATMENT OF OPIOID WITHDRAWAL IN MEDICALLY ILL HOSPITALIZED PATIENTS
- OPIOID DETOXIFICATION USING HIGH DOSES OF BUPRENORPHINE IN 24 HOURS: A RANDOMIZED, DOUBLE BLIND, CONTROLLED CLINICAL TRIAL
- BUPRENORPHINE TREATMENT FOR OPIOID DEPENDENCE: THE RELATIVE EFFICACY OF DAILY, TWICE AND THRICE WEEKLY DOSING